---
figid: PMC3824607__nihms-471006-f0001
figlink: /pmc/articles/PMC3824607/figure/F1/
number: Fig. 1
caption: TNFα-mediated transient IKK activation pathways. (A) Signaling pathways to
  full IKK activation. Upon ligation, TNFR1 recruits TRADD, RIP1, TRAF2, and cIAP1/2.
  TRAF2 and cIAP1/2, in conjunction with UbcH5, catalyze RIP1 ubiquitination through
  linear (M1-pUb) and K63 linkages (K63-pUb), and also undergo autoubiquitination
  through K63-linkage. K63-pUb recruits the TAK1-TAB1-TAB2 complex, and M1-pUb recruits
  the IKKα-IKKβ-NEMO complex, leading to TAK1-mediated activation of the early phase
  of IKK. Thereafter, K63-pUb recruits the HOIL-1L–HOIP complex, which in turn recruits
  and catalyzes linear ubiquitination of NEMO, leading to more IKK recruitment and
  full activation of IKK. Such full IKK activation is required for the efficient expression
  of NF-κB target genes. (B) RIP1-independent pathway to delayed IKK activation. RIP1
  protein is not detectable in embryonic hepatocytes. As a result, upon TNFR1 ligation,
  receptor-recruited TRAF2 and cIAP1/2 undergo increased autoubiquitination through
  K63 and K48 linkages. The K63-pUb chains then recruit the TAK1-TAB1-TAB2 and HOIP–HOIL-1
  complexes, leading to activation of the delayed phase of IKK. Such delayed IKK activation
  is sufficient for induction of some NF-κB target genes (e.g., IκBα and IP-10).
pmcid: PMC3824607
papertitle: 'TNFR1 Signaling Kinetics: Spatiotemporal Control of Three Phases of IKK
  activation by Posttranslational Modification.'
reftext: Lauren M. Workman, et al. Cell Signal. ;25(8):10.1016/j.cellsig.2013.04.005.
pmc_ranked_result_index: '99297'
pathway_score: 0.9413182
filename: nihms-471006-f0001.jpg
figtitle: TNFAlpha-mediated transient IKK activation pathways
year: ''
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3824607__nihms-471006-f0001.html
  '@type': Dataset
  description: TNFα-mediated transient IKK activation pathways. (A) Signaling pathways
    to full IKK activation. Upon ligation, TNFR1 recruits TRADD, RIP1, TRAF2, and
    cIAP1/2. TRAF2 and cIAP1/2, in conjunction with UbcH5, catalyze RIP1 ubiquitination
    through linear (M1-pUb) and K63 linkages (K63-pUb), and also undergo autoubiquitination
    through K63-linkage. K63-pUb recruits the TAK1-TAB1-TAB2 complex, and M1-pUb recruits
    the IKKα-IKKβ-NEMO complex, leading to TAK1-mediated activation of the early phase
    of IKK. Thereafter, K63-pUb recruits the HOIL-1L–HOIP complex, which in turn recruits
    and catalyzes linear ubiquitination of NEMO, leading to more IKK recruitment and
    full activation of IKK. Such full IKK activation is required for the efficient
    expression of NF-κB target genes. (B) RIP1-independent pathway to delayed IKK
    activation. RIP1 protein is not detectable in embryonic hepatocytes. As a result,
    upon TNFR1 ligation, receptor-recruited TRAF2 and cIAP1/2 undergo increased autoubiquitination
    through K63 and K48 linkages. The K63-pUb chains then recruit the TAK1-TAB1-TAB2
    and HOIP–HOIL-1 complexes, leading to activation of the delayed phase of IKK.
    Such delayed IKK activation is sufficient for induction of some NF-κB target genes
    (e.g., IκBα and IP-10).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IKBKB
  - IKBKG
  - CXCL10
  - TRAF2
  - CHUK
  - TNF
  - TNFRSF1A
  - IL6
  - TRADD
  - KRR1
  - TAB1
  - NR2C2
  - TAB2
  - RNF31
  - NFKB1
  - RBCK1
  - BIRC3
  - BIRC2
  - CCL5
genes:
- word: IKKB
  symbol: IKK-beta
  source: hgnc_alias_symbol
  hgnc_symbol: IKBKB
  entrez: '3551'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKG
  entrez: '8517'
- word: IP-10
  symbol: IP-10
  source: hgnc_alias_symbol
  hgnc_symbol: CXCL10
  entrez: '3627'
- word: TRAF2
  symbol: TRAF2
  source: hgnc_symbol
  hgnc_symbol: TRAF2
  entrez: '7186'
- word: NEMO
  symbol: NEMO
  source: hgnc_alias_symbol
  hgnc_symbol: IKBKG
  entrez: '8517'
- word: IKKA
  symbol: IKK-alpha
  source: hgnc_alias_symbol
  hgnc_symbol: CHUK
  entrez: '1147'
- word: TNFA/TNFR1
  symbol: TNF-alpha
  source: hgnc_alias_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKB
  entrez: '3551'
- word: TNFA/TNFR1
  symbol: TNFR1
  source: hgnc_prev_symbol
  hgnc_symbol: TNFRSF1A
  entrez: '7132'
- word: IL-6
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: TRADD
  symbol: TRADD
  source: hgnc_symbol
  hgnc_symbol: TRADD
  entrez: '8717'
- word: RIP1
  symbol: RIP-1
  source: hgnc_alias_symbol
  hgnc_symbol: KRR1
  entrez: '11103'
- word: TAB1
  symbol: TAB1
  source: hgnc_symbol
  hgnc_symbol: TAB1
  entrez: '10454'
- word: TAK1
  symbol: TAK1
  source: hgnc_alias_symbol
  hgnc_symbol: NR2C2
  entrez: '7182'
- word: TAB2
  symbol: TAB2
  source: hgnc_symbol
  hgnc_symbol: TAB2
  entrez: '23118'
- word: HOIP
  symbol: HOIP
  source: hgnc_alias_symbol
  hgnc_symbol: RNF31
  entrez: '55072'
- word: NF-KB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: CHUK
  entrez: '1147'
- word: HOIL-1
  symbol: HOIL1
  source: hgnc_alias_symbol
  hgnc_symbol: RBCK1
  entrez: '10616'
- word: CIAP1/2
  symbol: c-IAP2
  source: hgnc_alias_symbol
  hgnc_symbol: BIRC3
  entrez: '330'
- word: CIAP1/2
  symbol: c-IAP1
  source: hgnc_alias_symbol
  hgnc_symbol: BIRC2
  entrez: '329'
- word: RANTES
  symbol: RANTES
  source: hgnc_alias_symbol
  hgnc_symbol: CCL5
  entrez: '6352'
chemicals: []
diseases: []
---
